Provided by Tiger Trade Technology Pte. Ltd.

Daxor

12.35
+0.08500.69%
Post-market: 12.350.00000.00%16:04 EST
Volume:1.27K
Turnover:15.74K
Market Cap:71.94M
PE:34.23
High:12.59
Open:12.35
Low:12.35
Close:12.26
52wk High:14.76
52wk Low:6.55
Shares:5.83M
Float Shares:2.97M
Volume Ratio:0.32
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3606
EPS(LYR):0.1087
ROE:5.26%
ROA:-2.51%
PB:2.02
PE(LYR):113.57

Loading ...

Daxor Files Legal Opinion Affirming Validity of Stock

TIPRANKS
·
Jan 27

Daxor Corporation Announces $9 Million Registered Direct Offering

GlobeNewswire
·
Jan 23

Daxor Releases Updated Investor Presentation to Public Markets

TIPRANKS
·
Jan 23

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

GlobeNewswire
·
Nov 25, 2025

Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit

GlobeNewswire
·
Oct 21, 2025

Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25

GlobeNewswire
·
Oct 15, 2025

Daxor Corporation Files Initial Statement of Beneficial Ownership for Chief Medical Officer John Jefferies

Reuters
·
Oct 03, 2025

Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA

GlobeNewswire
·
Sep 30, 2025

Daxor unveils next-gen BVA analyzer at HFSA annual meeting

TIPRANKS
·
Sep 23, 2025

Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting

GlobeNewswire
·
Sep 23, 2025

Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care

GlobeNewswire
·
Sep 04, 2025

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

GlobeNewswire
·
Sep 02, 2025

Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available

GlobeNewswire
·
Aug 12, 2025

Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System

GlobeNewswire
·
Aug 07, 2025